Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve

Nalini M. Rajamannan, M. Subramaniam, S. R. Stock, N. J. Stone, M. Springett, K. I. Ignatiev, J. P. McConnell, R. J. Singh, R. O. Bonow, T. C. Spelsberg

Research output: Contribution to journalArticle

131 Scopus citations

Abstract

Objective: To study in a rabbit model the expression of endothelial nitric oxide synthase (eNOS) in association with the development of calcification of the aortic valve, and to assess the effects of atorvastatin on eNOS expression, nitrite concentration, and aortic valve calcification. Methods: Rabbits (n = 48) were treated for three months: 16, forming a control group, were fed a normal diet; 16 were fed a 0.5% (wt/wt) high cholesterol diet; and 16 were fed a 0.5% (wt/wt) cholesterol diet plus atorvastatin (2.5 mg/kg/day). The aortic valves were examined with eNOS immunostains and western blotting. Cholesterol and high sensitivity C reactive protein (hsCRP) concentrations were determined by standard assays. Serum nitrite concentrations were measured with a nitric oxide analyser. eNOS was localised by electron microscopy and immunogold labelling. Calcification in the aortic valve was evaluated by micro-computed tomography (CT). Results: Cholesterol, hsCRP, and aortic valve calcification were increased in the cholesterol fed compared with control animals. Atorvastatin inhibited calcification in the aortic valve as assessed by micro-CT. eNOS protein concentrations were unchanged in the control and cholesterol groups but increased in the atorvastatin treated group. Serum nitrite concentrations were decreased in the hypercholesterolaemic animals and increased in the group treated with atorvastatin. Conclusion: These data provide evidence that chronic experimental hypercholesterolaemia produces bone mineralisation in the aortic valve, which is inhibited by atorvastatin.

Original languageEnglish (US)
Pages (from-to)806-810
Number of pages5
JournalHeart
Volume91
Issue number6
DOIs
StatePublished - Jun 1 2005

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve'. Together they form a unique fingerprint.

  • Cite this

    Rajamannan, N. M., Subramaniam, M., Stock, S. R., Stone, N. J., Springett, M., Ignatiev, K. I., McConnell, J. P., Singh, R. J., Bonow, R. O., & Spelsberg, T. C. (2005). Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart, 91(6), 806-810. https://doi.org/10.1136/hrt.2003.029785